Please note: AABB reserves the right to make updates to this program.
Tuesday, May 9, 2019 - [Rescheduled from 12/04/18]
12:00 – 1:00 PM (ET) 4:00 – 5:00 PM (GMT) - please note start time as it differs from our regular eCast start time.
Master Program Number: 18EL-338 (see program format numbers below under Registration)
Educational Track: Technical/Clinical
Topic: Transfusion Medicine (Hemovigilance)
Intended Audience: Hospital Blood Banks, Medical Directors, Nurses, Physicians
Teaching Level: Intermediate
Director: Srijana Rajbhandary, BDS, MPH, Research and Data Analyst, AABB, Bethesda, MD
Moderator: Mark Fung, MD, PhD, Director of Clinical Laboratories, University of Vermont Medical Center, Burlington, VT
Speakers: Mark Fung, MD, PhD, Director of Clinical Laboratories, University of Vermont Medical Center, Burlington, VT; YanYun Wu, MD, PhD, Immunohematology & RBC Genomics Reference Laboratory, BloodworksNW, Seattle, WA; Kathleen Puca, MD, Senior Medical Director, BloodCenter of Wisconsin, Part of Versiti, Milwaukee, WI
After participating in this educational activity, participants should be able to:
- Discuss the role of reporting transfusion reactions to your blood supplier.
- Identify common and uncommon transfusion reactions that should be reported.
- Describe the Common Transfusion Reaction Reporting form.
- Describe the protocol to use the form.
Reporting to the blood collection establishment (BCE) of Transfusion Adverse Reactions (TARs) thought to be due to an attribute specific to the donor or the processing of the blood product is necessary to enable the BCE to take action on co-components and manage donor eligibility. Many hospitals use more than one blood supplier and complete several different forms when there is a multiple transfused patient who has a reaction. Representatives from hospitals and blood suppliers recognized this challenge and developed the AABB Common Transfusion Adverse Reaction Reporting Form to simplify hospital communication with blood centers. This eCast will discuss when reactions should be reported to a blood supplier and include an overview of the form and examples of use of the form in the daily communications between blood suppliers and their hospital customers.
| || ||
|Single Viewer: Live||
|Single Viewer: On-Demand||
|Group Viewing: Live||
|Group Viewing: On-Demand||
|Group Viewing: Live & On-Demand||
Continuing Education Credit
AABB estimates both the live and on-demand version of this eCast each to be eligible for 1.0 continuing education credits/contact hours for Physicians, California Nurse, California Lab Personnel, Florida Lab Personnel and General Participation credit. The final number of credit(s) and credit types awarded for this program (live or on-demand) will be determined by the program duration. For more information on each credit type please visit our
Continuing Education Credits webpage.
Dr. Mark Fung is professor of pathology and laboratory medicine at the University of Vermont and is vice chair of quality and clinical affairs for Pathology and Laboratory Medicine at the University of Vermont Health Network, and director of clinical laboratories at University of Vermont Medical Center. Dr. Fung has served in a number of leadership capacities within the AABB and other related organizations. These activities include the development of multiple transfusion guidelines and the implementation of transfusion reaction reporting using standardized definitions. He is the editor-in-chief for the 18th and upcoming 19th editions of the AABB Technical Manual.